Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...

After assuming the charges of portfolios on Friday, the Health and Transport Minister Dr Pankaj Singh on Friday said a probe ...

Delhi's new BJP-led administration announced a significant healthcare reform strategy, addressing staffing shortages, ...

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.

Stock futures rise as traders eye Fed minutes and tariffs. Tesla, Intel, and Buffett-backed Constellation lead pre-market ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...

The FDA just slammed the door on its booming weight-loss drug business--but Hims & Hers has a bold new strategy.

Hims & Hers Health (HIMS) is jumping 15% after the company announced that it had made an acquisition which will allow it to ...